Interleukin-6 (-636 C/G) gene polymorphism in Korean children with Kawasaki disease

Korean Circulation Journal

Volumn 41, Issue 6, 2011, Pages 321-326

  Ahn, Hye Mi ^a   Park, In Sook ^b   Hong, Soo Jong ^b   Hong, Young Mi ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Genetic; Interleukins; Mucocutaneous lymph node syndrome; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIAC PATIENT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; KOREA; LABORATORY TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; NEUTROPHIL COUNT; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT;

EID: 79960609094     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.6.321     Document Type: Article

References (29)

1. Yeo JS, Choi JW. Effectiveness of medium-dose intravenous immunoglobulin (1 g/kg) in the treatment of Kawasaki disease. Korean Circ J 2010;40:81-5.
2. Lee SJ, Ahn HM, Yoo JH, Hong YM. Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki disease. Korean Circ J 2009;39:264-9.
3. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease infection, immunity and genetics. Pediatr Infect Dis J 2005;24:998-1004.
4. Fulton DR, Newberger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000;2:324-9.
5. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10-to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85.
6. Lloyd AJ, Walker C, Wilkinso M. Kawasaki disease: is it caused by an infectious agent? Br J Biomed Sci 2001;58:122-8.
7. Liang SJ, Cheong HI, Noh CI, Yun YS. Role of anti-endothelial cell antibody in the development of coronary arterial lesions in Kawasaki disease. Korean Circ J 2006;36:723-31.
8. Maury CP, Salo E, Pelkonen D. Circulating interleukin-1 beta inpatients with Kawasaki disease. N Engl J Med 1988;319:1670-1.
9. Ueno Y, Takano N, Kanegane H, et al. The acute phase nature of interluekin-6: studies in Kawasaki disease and other febrile illness. Clin Exp Immunol 1989;76:337-42.
10. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interluekin-6. Immunol Today 1990;11:443-9.
11. Tanaka C, Mannami T, Kamide K, et al. Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 2005;28:35-41.
12. Kim MK, Kim DS. The interleukin-6 level in Kawasaki disease. J Korean Pediatr Soc 1992;35:515-26.
13. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
14. Hong YM, Jin HS, Park IS, Hong SJ. Association of the matrix metalloproteinase-3 (-439C/G) gene polymorphism with Kawasaki disease in Korean children. Heart Vessels 2008;23:341-7.
15. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997;112:152-6.
16. Cheung YF, Huang GY, Chen CB, et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 2008;122:e608-14.
17. Leung DY, Geha RS, Newberger JW, et al. Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986;164:1958-72.
18. Hata A, Onouchi Y. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine. J Hum Genet 2009;54:67-73.
19. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252:283-94.
20. Zee RY, Cook NR, Cheng S, et al. Polymorphism in the P seletin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Gent 2004;13:389-96.
21. Chapman CM, Beilby JP, Humphries SE, Palmer LJ, Thompson PL, Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 2003;24:1494-9.
22. Jibiki T, Terai M, Shima M, et al. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001;44:2211-2.
23. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
24. Burns JC, Shimizu C, Shike H, et al. Family-based association analysis implications IL-4 in susceptibility to Kawasaki disease. Genes Immun 2005;6:438-44.
25. Jin HS, Kim HB, Kim BS, et al. The IL-10 (-627 A/C) gene polymorphism may be associated with coronary aneurysms and low albumin in Korean children with Kawasaki disease. Pediatr Res 2007;61:584-7.
26. Linker-Israeli M, Wallace DJ, Prehn JL, Nand R, Li L, Klinenberg JR. A greater variability in the 3′flanking region of the IL-6 gene inpatients with systemic lupus erythematosus (SLE). Autoimmunity 1996;23:199-209.
27. Papassotiropulos A, Bagli M, Jessen F, et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 1999;45:666-8.
28. Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE. The interleukin-6 gene -174G>C and -572G>C gene polymorphisms are related to cerebral aneurysm. J Neuro Neurosurg Psychiatry 2006;77:915-7.
29. Sohn MH, Hur MW, Kim DS. Interleukin-6 gene gene polymorphism is not associated with Kawasaki disease. Genes Immun 2001;2:357-62.